Dr. Kewei Yang is working as a pharmaceutical scientist and project leader in F. Hoffmann-La Roche Ltd. in Switzerland since 2014, specializing in the development of parenteral drug products for both small and large molecular, manufacturing process development, as well as device combination products.
Before that he has worked on the development of nano-medicine for parenteral application in Novartis in Switzerland.
Dr. Yang studied pharmaceutical science in Peking University in China and obtained his PhD degree of pharmaceutical technology in Friedlich Schiller University of Jena in Germany. By now he has published dozens of peer-reviewed papers and holds a few patents.